PRO CON DEBATE | ANTICOAGULATION VERSUS ENDOVASCULAR THERAPY FOR ACUTE PULMONARY EMBOLISM

Monday, March 10, 2025

11:30 AM - 12:00 PM ET

Moderator(s)

Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure(s): Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)
Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure(s): Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

Panel Discussant(s)

Mark C. Bates, MD, DSc, FSCAI

Clinical Professor of Medicine and Surgery
CAMC Institute of Academic Medicine and WVU
Charleston, West Virginia, United States

No relationships to disclose
Mark C. Bates, MD, DSc, FSCAI

Clinical Professor of Medicine and Surgery
CAMC Institute of Academic Medicine and WVU
Charleston, West Virginia, United States

No relationships to disclose
Torrey Schmidt, DO

Director, Pulmonary Embolism Interventional Program
UPMC Harrisburg
Enola, Pennsylvania, United States

No relationships to disclose
Torrey Schmidt, DO

Director, Pulmonary Embolism Interventional Program
UPMC Harrisburg
Enola, Pennsylvania, United States

No relationships to disclose
Sanjum S. Sethi, MD MPH

Assistant Professor of Medicine
NewYork-Presbyterian Columbia University Irving Medical Center
New York, New York, United States

Disclosure(s): Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Inari Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Janssen Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Penumbra, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)
Sanjum S. Sethi, MD MPH

Assistant Professor of Medicine
NewYork-Presbyterian Columbia University Irving Medical Center
New York, New York, United States

Disclosure(s): Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Inari Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Janssen Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Penumbra, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Kenneth Rosenfield, MD, MHCDS: Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

Mark C. Bates, MD, DSc, FSCAI: Avobis Bio: Board Chair (Ongoing); WL Gore & Associates: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)

Torrey Schmidt, DO: No financial relationships to disclose

Sanjum S. Sethi, MD MPH: Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Inari Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Janssen Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Penumbra, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)